Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Drug Screening System Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Drug Screening System Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 161 Pages
Report ld: 5347347
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Drug Screening System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Drug Screening System leading manufacturers including Hamamatsu Photonics, Abbott Toxicology, Dräger, Quest Diagnostics, BMG Labtech, ThermoFisher, Siemens Healthineers, DISA, eScreen, Agilent, etc., dominate supply; the top five capture approximately % of global revenue, with Hamamatsu Photonics leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Drug Screening System market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Hamamatsu Photonics
- Abbott Toxicology
- Dräger
- Quest Diagnostics
- BMG Labtech
- ThermoFisher
- Siemens Healthineers
- DISA
- eScreen
- Agilent
- Smiths Group
- FPI
- Biotests
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Mobile Drug Screening System
- Stationary Drug Screening System
Segment by Application
- Hospital
- Government
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Drug Screening System study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Drug Screening System: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Drug Screening System Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Mobile Drug Screening System
1.2.3 Stationary Drug Screening System
1.3 Market Segmentation by Application
1.3.1 Global Drug Screening System Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Government
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Drug Screening System Revenue Estimates and Forecasts 2020-2031
2.2 Global Drug Screening System Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Drug Screening System Sales Estimates and Forecasts 2020-2031
2.4 Global Drug Screening System Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Drug Screening System Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Drug Screening System Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Mobile Drug Screening System Market Size by Manufacturers
3.5.2 Stationary Drug Screening System Market Size by Manufacturers
3.6 Global Drug Screening System Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Drug Screening System Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Drug Screening System Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Drug Screening System Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Drug Screening System Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Drug Screening System Sales and Revenue by Type (2020-2031)
6.4 North America Drug Screening System Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Drug Screening System Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Drug Screening System Sales and Revenue by Type (2020-2031)
7.4 Europe Drug Screening System Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Drug Screening System Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Drug Screening System Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Drug Screening System Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Drug Screening System Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Drug Screening System Sales and Revenue by Type (2020-2031)
9.4 Central and South America Drug Screening System Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Drug Screening System Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Drug Screening System Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Drug Screening System Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Drug Screening System Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Hamamatsu Photonics
11.1.1 Hamamatsu Photonics Corporation Information
11.1.2 Hamamatsu Photonics Business Overview
11.1.3 Hamamatsu Photonics Drug Screening System Product Models, Descriptions and Specifications
11.1.4 Hamamatsu Photonics Drug Screening System Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Hamamatsu Photonics Drug Screening System Sales by Product in 2024
11.1.6 Hamamatsu Photonics Drug Screening System Sales by Application in 2024
11.1.7 Hamamatsu Photonics Drug Screening System Sales by Geographic Area in 2024
11.1.8 Hamamatsu Photonics Drug Screening System SWOT Analysis
11.1.9 Hamamatsu Photonics Recent Developments
11.2 Abbott Toxicology
11.2.1 Abbott Toxicology Corporation Information
11.2.2 Abbott Toxicology Business Overview
11.2.3 Abbott Toxicology Drug Screening System Product Models, Descriptions and Specifications
11.2.4 Abbott Toxicology Drug Screening System Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Abbott Toxicology Drug Screening System Sales by Product in 2024
11.2.6 Abbott Toxicology Drug Screening System Sales by Application in 2024
11.2.7 Abbott Toxicology Drug Screening System Sales by Geographic Area in 2024
11.2.8 Abbott Toxicology Drug Screening System SWOT Analysis
11.2.9 Abbott Toxicology Recent Developments
11.3 Dräger
11.3.1 Dräger Corporation Information
11.3.2 Dräger Business Overview
11.3.3 Dräger Drug Screening System Product Models, Descriptions and Specifications
11.3.4 Dräger Drug Screening System Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Dräger Drug Screening System Sales by Product in 2024
11.3.6 Dräger Drug Screening System Sales by Application in 2024
11.3.7 Dräger Drug Screening System Sales by Geographic Area in 2024
11.3.8 Dräger Drug Screening System SWOT Analysis
11.3.9 Dräger Recent Developments
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Corporation Information
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Drug Screening System Product Models, Descriptions and Specifications
11.4.4 Quest Diagnostics Drug Screening System Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Quest Diagnostics Drug Screening System Sales by Product in 2024
11.4.6 Quest Diagnostics Drug Screening System Sales by Application in 2024
11.4.7 Quest Diagnostics Drug Screening System Sales by Geographic Area in 2024
11.4.8 Quest Diagnostics Drug Screening System SWOT Analysis
11.4.9 Quest Diagnostics Recent Developments
11.5 BMG Labtech
11.5.1 BMG Labtech Corporation Information
11.5.2 BMG Labtech Business Overview
11.5.3 BMG Labtech Drug Screening System Product Models, Descriptions and Specifications
11.5.4 BMG Labtech Drug Screening System Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 BMG Labtech Drug Screening System Sales by Product in 2024
11.5.6 BMG Labtech Drug Screening System Sales by Application in 2024
11.5.7 BMG Labtech Drug Screening System Sales by Geographic Area in 2024
11.5.8 BMG Labtech Drug Screening System SWOT Analysis
11.5.9 BMG Labtech Recent Developments
11.6 ThermoFisher
11.6.1 ThermoFisher Corporation Information
11.6.2 ThermoFisher Business Overview
11.6.3 ThermoFisher Drug Screening System Product Models, Descriptions and Specifications
11.6.4 ThermoFisher Drug Screening System Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 ThermoFisher Recent Developments
11.7 Siemens Healthineers
11.7.1 Siemens Healthineers Corporation Information
11.7.2 Siemens Healthineers Business Overview
11.7.3 Siemens Healthineers Drug Screening System Product Models, Descriptions and Specifications
11.7.4 Siemens Healthineers Drug Screening System Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Siemens Healthineers Recent Developments
11.8 DISA
11.8.1 DISA Corporation Information
11.8.2 DISA Business Overview
11.8.3 DISA Drug Screening System Product Models, Descriptions and Specifications
11.8.4 DISA Drug Screening System Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 DISA Recent Developments
11.9 eScreen
11.9.1 eScreen Corporation Information
11.9.2 eScreen Business Overview
11.9.3 eScreen Drug Screening System Product Models, Descriptions and Specifications
11.9.4 eScreen Drug Screening System Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 eScreen Recent Developments
11.10 Agilent
11.10.1 Agilent Corporation Information
11.10.2 Agilent Business Overview
11.10.3 Agilent Drug Screening System Product Models, Descriptions and Specifications
11.10.4 Agilent Drug Screening System Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Agilent Recent Developments
11.11 Smiths Group
11.11.1 Smiths Group Corporation Information
11.11.2 Smiths Group Business Overview
11.11.3 Smiths Group Drug Screening System Product Models, Descriptions and Specifications
11.11.4 Smiths Group Drug Screening System Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Smiths Group Recent Developments
11.12 FPI
11.12.1 FPI Corporation Information
11.12.2 FPI Business Overview
11.12.3 FPI Drug Screening System Product Models, Descriptions and Specifications
11.12.4 FPI Drug Screening System Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 FPI Recent Developments
11.13 Biotests
11.13.1 Biotests Corporation Information
11.13.2 Biotests Business Overview
11.13.3 Biotests Drug Screening System Product Models, Descriptions and Specifications
11.13.4 Biotests Drug Screening System Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Biotests Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Drug Screening System Industry Chain
12.2 Drug Screening System Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Drug Screening System Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Drug Screening System Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Drug Screening System Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Drug Screening System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Drug Screening System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Drug Screening System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Drug Screening System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Drug Screening System Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Drug Screening System Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Drug Screening System Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Drug Screening System Sales by Region (2020-2025) & (K Units)
Table 8. Global Drug Screening System Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Drug Screening System Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Drug Screening System Sales Share by Manufacturers (2020-2025)
Table 12. Global Drug Screening System Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Drug Screening System Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Drug Screening System by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Screening System as of 2024)
Table 16. Global Drug Screening System Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Drug Screening System Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Drug Screening System Manufacturing Base and Headquarters
Table 19. Global Drug Screening System Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Drug Screening System Sales by Type (2020-2025) & (K Units)
Table 23. Global Drug Screening System Sales by Type (2026-2031) & (K Units)
Table 24. Global Drug Screening System Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Drug Screening System Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Drug Screening System ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Drug Screening System Sales by Application (2020-2025) & (K Units)
Table 29. Global Drug Screening System Sales by Application (2026-2031) & (K Units)
Table 30. Drug Screening System High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Drug Screening System Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Drug Screening System Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Drug Screening System ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Drug Screening System Growth Accelerators and Market Barriers
Table 37. North America Drug Screening System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Drug Screening System Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Drug Screening System Growth Accelerators and Market Barriers
Table 40. Europe Drug Screening System Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Drug Screening System Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Drug Screening System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Drug Screening System Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Drug Screening System Growth Accelerators and Market Barriers
Table 45. Southeast Asia Drug Screening System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Drug Screening System Investment Opportunities and Key Challenges
Table 47. Central and South America Drug Screening System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Drug Screening System Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Drug Screening System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Hamamatsu Photonics Corporation Information
Table 51. Hamamatsu Photonics Description and Major Businesses
Table 52. Hamamatsu Photonics Product Models, Descriptions and Specifications
Table 53. Hamamatsu Photonics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Hamamatsu Photonics Sales Value Proportion by Product in 2024
Table 55. Hamamatsu Photonics Sales Value Proportion by Application in 2024
Table 56. Hamamatsu Photonics Sales Value Proportion by Geographic Area in 2024
Table 57. Hamamatsu Photonics Drug Screening System SWOT Analysis
Table 58. Hamamatsu Photonics Recent Developments
Table 59. Abbott Toxicology Corporation Information
Table 60. Abbott Toxicology Description and Major Businesses
Table 61. Abbott Toxicology Product Models, Descriptions and Specifications
Table 62. Abbott Toxicology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Abbott Toxicology Sales Value Proportion by Product in 2024
Table 64. Abbott Toxicology Sales Value Proportion by Application in 2024
Table 65. Abbott Toxicology Sales Value Proportion by Geographic Area in 2024
Table 66. Abbott Toxicology Drug Screening System SWOT Analysis
Table 67. Abbott Toxicology Recent Developments
Table 68. Dräger Corporation Information
Table 69. Dräger Description and Major Businesses
Table 70. Dräger Product Models, Descriptions and Specifications
Table 71. Dräger Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Dräger Sales Value Proportion by Product in 2024
Table 73. Dräger Sales Value Proportion by Application in 2024
Table 74. Dräger Sales Value Proportion by Geographic Area in 2024
Table 75. Dräger Drug Screening System SWOT Analysis
Table 76. Dräger Recent Developments
Table 77. Quest Diagnostics Corporation Information
Table 78. Quest Diagnostics Description and Major Businesses
Table 79. Quest Diagnostics Product Models, Descriptions and Specifications
Table 80. Quest Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Quest Diagnostics Sales Value Proportion by Product in 2024
Table 82. Quest Diagnostics Sales Value Proportion by Application in 2024
Table 83. Quest Diagnostics Sales Value Proportion by Geographic Area in 2024
Table 84. Quest Diagnostics Drug Screening System SWOT Analysis
Table 85. Quest Diagnostics Recent Developments
Table 86. BMG Labtech Corporation Information
Table 87. BMG Labtech Description and Major Businesses
Table 88. BMG Labtech Product Models, Descriptions and Specifications
Table 89. BMG Labtech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. BMG Labtech Sales Value Proportion by Product in 2024
Table 91. BMG Labtech Sales Value Proportion by Application in 2024
Table 92. BMG Labtech Sales Value Proportion by Geographic Area in 2024
Table 93. BMG Labtech Drug Screening System SWOT Analysis
Table 94. BMG Labtech Recent Developments
Table 95. ThermoFisher Corporation Information
Table 96. ThermoFisher Description and Major Businesses
Table 97. ThermoFisher Product Models, Descriptions and Specifications
Table 98. ThermoFisher Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. ThermoFisher Recent Developments
Table 100. Siemens Healthineers Corporation Information
Table 101. Siemens Healthineers Description and Major Businesses
Table 102. Siemens Healthineers Product Models, Descriptions and Specifications
Table 103. Siemens Healthineers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Siemens Healthineers Recent Developments
Table 105. DISA Corporation Information
Table 106. DISA Description and Major Businesses
Table 107. DISA Product Models, Descriptions and Specifications
Table 108. DISA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. DISA Recent Developments
Table 110. eScreen Corporation Information
Table 111. eScreen Description and Major Businesses
Table 112. eScreen Product Models, Descriptions and Specifications
Table 113. eScreen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. eScreen Recent Developments
Table 115. Agilent Corporation Information
Table 116. Agilent Description and Major Businesses
Table 117. Agilent Product Models, Descriptions and Specifications
Table 118. Agilent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Agilent Recent Developments
Table 120. Smiths Group Corporation Information
Table 121. Smiths Group Description and Major Businesses
Table 122. Smiths Group Product Models, Descriptions and Specifications
Table 123. Smiths Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Smiths Group Recent Developments
Table 125. FPI Corporation Information
Table 126. FPI Description and Major Businesses
Table 127. FPI Product Models, Descriptions and Specifications
Table 128. FPI Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. FPI Recent Developments
Table 130. Biotests Corporation Information
Table 131. Biotests Description and Major Businesses
Table 132. Biotests Product Models, Descriptions and Specifications
Table 133. Biotests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Biotests Recent Developments
Table 135. Key Raw Materials Distribution
Table 136. Raw Materials Key Suppliers
Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 138. Milestones in Production Technology Evolution
Table 139. Distributors List
Table 140. Market Trends and Market Evolution
Table 141. Market Drivers and Opportunities
Table 142. Market Challenges, Risks, and Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Screening System Product Picture
Figure 2. Global Drug Screening System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Mobile Drug Screening System Product Picture
Figure 4. Stationary Drug Screening System Product Picture
Figure 5. Global Drug Screening System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Government
Figure 8. Others
Figure 9. Drug Screening System Report Years Considered
Figure 10. Global Drug Screening System Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Drug Screening System Revenue (2020-2031) & (US$ Million)
Figure 12. Global Drug Screening System Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Drug Screening System Revenue Market Share by Region (2020-2031)
Figure 14. Global Drug Screening System Sales (2020-2031) & (K Units)
Figure 15. Global Drug Screening System Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global Drug Screening System Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Drug Screening System Sales Volume Market Share in 2024
Figure 18. Global Drug Screening System Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Mobile Drug Screening System Revenue Market Share by Manufacturer in 2024
Figure 21. Stationary Drug Screening System Revenue Market Share by Manufacturer in 2024
Figure 22. Global Drug Screening System Sales Market Share by Type (2020-2031)
Figure 23. Global Drug Screening System Revenue Market Share by Type (2020-2031)
Figure 24. Global Drug Screening System Sales Market Share by Application (2020-2031)
Figure 25. Global Drug Screening System Revenue Market Share by Application (2020-2031)
Figure 26. North America Drug Screening System Sales YoY (2020-2031) & (K Units)
Figure 27. North America Drug Screening System Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Drug Screening System Sales Revenue (US$ Million) in 2024
Figure 29. North America Drug Screening System Sales Volume (K Units) by Type (2020- 2031)
Figure 30. North America Drug Screening System Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Drug Screening System Sales Volume (K Units) by Application (2020-2031)
Figure 32. North America Drug Screening System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Drug Screening System Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Drug Screening System Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Drug Screening System Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Drug Screening System Sales YoY (2020-2031) & (K Units)
Figure 37. Europe Drug Screening System Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Drug Screening System Sales Revenue (US$ Million) in 2024
Figure 39. Europe Drug Screening System Sales Volume (K Units) by Type (2020-2031)
Figure 40. Europe Drug Screening System Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Drug Screening System Sales Volume (K Units) by Application (2020-2031)
Figure 42. Europe Drug Screening System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Drug Screening System Revenue (2020-2031) & (US$ Million)
Figure 44. France Drug Screening System Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Drug Screening System Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Drug Screening System Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Drug Screening System Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Drug Screening System Sales YoY (2020-2031) & (K Units)
Figure 49. Asia-Pacific Drug Screening System Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Drug Screening System Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Drug Screening System Sales Volume (K Units) by Type (2020- 2031)
Figure 52. Asia-Pacific Drug Screening System Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Drug Screening System Sales Volume (K Units) by Application (2020-2031)
Figure 54. Asia-Pacific Drug Screening System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Drug Screening System Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Drug Screening System Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Drug Screening System Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Drug Screening System Revenue (2020-2031) & (US$ Million)
Figure 59. India Drug Screening System Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Drug Screening System Sales YoY (2020-2031) & (K Units)
Figure 61. Central and South America Drug Screening System Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Drug Screening System Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Drug Screening System Sales Volume (K Units) by Type (2021-2031)
Figure 64. Central and South America Drug Screening System Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Drug Screening System Sales Volume (K Units) by Application (2020-2031)
Figure 66. Central and South America Drug Screening System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Drug Screening System Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Drug Screening System Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Drug Screening System Sales YoY (2020-2031) & (K Units)
Figure 70. Middle East and Africa Drug Screening System Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Drug Screening System Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Drug Screening System Sales Volume (K Units) by Type (2021-2031)
Figure 73. South America Drug Screening System Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Drug Screening System Sales Volume (K Units) by Application (2020-2031)
Figure 75. Middle East and Africa Drug Screening System Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Drug Screening System Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Drug Screening System Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Drug Screening System Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Drug Screening System Revenue (2020-2025) & (US$ Million)
Figure 80. Drug Screening System Industry Chain Mapping
Figure 81. Regional Drug Screening System Manufacturing Base Distribution (%)
Figure 82. Global Drug Screening System Production Market Share by Region (2020-2031)
Figure 83. Drug Screening System Production Process
Figure 84. Regional Drug Screening System Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Drug Screening System market?
The top companies in the global Drug Screening System market are Hamamatsu Photonics、Abbott Toxicology、Dräger.
Related Reports
Drug Screening System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Drug Screening System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 144
USD 3950.00
(Single User License)
Global Drug Screening System Market Research Report 2026
The global Drug Screening System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 121
USD 2900.00
(Single User License)
Global Drug Screening System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Drug Screening System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 92
USD 4250.00
(Single User License)
Drug Screening System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Drug Screening System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 128
USD 3950.00
(Single User License)
Global Drug Screening System Market Research Report 2025
The global market for Drug Screening System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 92
USD 2900.00
(Single User License)
Global Drug Screening System Market Research Report 2024
The global Drug Screening System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 89
USD 2900.00
(Single User License)
Drug Screening System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Drug Screening System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 144
USD 3950.00 (Single User License)Global Drug Screening System Market Research Report 2026
The global Drug Screening System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 121
USD 2900.00 (Single User License)Global Drug Screening System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Drug Screening System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 92
USD 4250.00 (Single User License)Drug Screening System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Drug Screening System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 128
USD 3950.00 (Single User License)Global Drug Screening System Market Research Report 2025
The global market for Drug Screening System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 92
USD 2900.00 (Single User License)Global Drug Screening System Market Research Report 2024
The global Drug Screening System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 89
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now